Koyfin Home > Directory > Health Care > Amgen Inc > EBITDA Margin

Amgen Inc EBITDA Margin Chart (AMGN)

Amgen Inc annual/quarterly EBITDA Margin from 2010 to 2020. An EBITDA margin is a measurement of a company's earnings before interest, taxes, depreciation, and amortization as a percentage of its total revenue.
  • Amgen Inc EBITDA Margin for the quarter ending September 09, 2020 was $52m a 18.85% increase of 10m year over year
  • Amgen Inc EBITDA Margin for the last 12 months ending September 09, 2020 was $51m a 0.58% increase of 0m year over year
  • Amgen Inc Annual EBITDA Margin for 2019 was $50m a -4.45% decrease of -2m from 2018
  • Amgen Inc Annual EBITDA Margin for 2018 was $53m a -1.96% decrease of -1m from 2017
  • Amgen Inc Annual EBITDA Margin for 2017 was $54m a 3.11% increase of 2m from 2016
Other Margins & Efficiency Metrics:
  • Amgen Inc Return on Capital % for the quarter ending December 12, 2018 was 12.51 a 2.64% increase of 0.33 year over year
  • Amgen Inc Return on Equity % for the quarter ending December 12, 2018 was 57.45 a 21.24% increase of 12.20 year over year
View Chart On Koyfin

Quarterly AMGN EBITDA Margin Data

09/2020$52m
06/2020$52m
03/2020$53m
12/2019$42m
09/2019$52m
06/2019$54m
03/2019$53m
12/2018$45m
09/2018$53m
06/2018$55m

Annual AMGN EBITDA Margin Data

2019$50m
2018$53m
2017$54m
2016$52m
2015$49m
2014$44m
2013$40m
2012$41m
2011$40m
2010$44m